Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.

Klein JC, Eggers C, Kalbe E, Weisenbach S, Hohmann C, Vollmar S, Baudrexel S, Diederich NJ, Heiss WD, Hilker R.

Neurology. 2010 Mar 16;74(11):885-92. doi: 10.1212/WNL.0b013e3181d55f61. Epub 2010 Feb 24.

PMID:
20181924
2.

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.

Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L, Jacobs AH, Herholz K, Heiss WD.

Neurology. 2005 Dec 13;65(11):1716-22.

PMID:
16344512
3.

Amyloid imaging of Lewy body-associated disorders.

Foster ER, Campbell MC, Burack MA, Hartlein J, Flores HP, Cairns NJ, Hershey T, Perlmutter JS.

Mov Disord. 2010 Nov 15;25(15):2516-23. doi: 10.1002/mds.23393.

PMID:
20922808
4.

A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.

Yong SW, Yoon JK, An YS, Lee PH.

Eur J Neurol. 2007 Dec;14(12):1357-62. Epub 2007 Oct 17.

PMID:
17941855
5.

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.

Shimada H, Hirano S, Shinotoh H, Aotsuka A, Sato K, Tanaka N, Ota T, Asahina M, Fukushi K, Kuwabara S, Hattori T, Suhara T, Irie T.

Neurology. 2009 Jul 28;73(4):273-8. doi: 10.1212/WNL.0b013e3181ab2b58. Epub 2009 May 27.

PMID:
19474411
6.

Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.

Colloby SJ, Williams ED, Burn DJ, Lloyd JJ, McKeith IG, O'Brien JT.

Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1176-85. Epub 2005 Jun 2.

PMID:
15931516
7.

Imaging amyloid deposition in Lewy body diseases.

Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA.

Neurology. 2008 Sep 16;71(12):903-10. doi: 10.1212/01.wnl.0000326146.60732.d6.

PMID:
18794492
8.

β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.

Shimada H, Shinotoh H, Hirano S, Miyoshi M, Sato K, Tanaka N, Ota T, Fukushi K, Irie T, Ito H, Higuchi M, Kuwabara S, Suhara T.

Mov Disord. 2013 Feb;28(2):169-75. doi: 10.1002/mds.25286. Epub 2012 Dec 5.

PMID:
23225334
9.

Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.

Borroni B, Premi E, Formenti A, Turrone R, Alberici A, Cottini E, Rizzetti C, Gasparotti R, Padovani A.

Parkinsonism Relat Disord. 2015 Sep;21(9):1049-55. doi: 10.1016/j.parkreldis.2015.06.013. Epub 2015 Jun 16.

PMID:
26109553
10.

In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.

Colloby SJ, Pakrasi S, Firbank MJ, Perry EK, Piggott MA, Owens J, Wyper DJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT.

Neuroimage. 2006 Nov 1;33(2):423-9. Epub 2006 Sep 7.

PMID:
16959499
11.

Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

Beyer MK, Larsen JP, Aarsland D.

Neurology. 2007 Aug 21;69(8):747-54.

PMID:
17709706
12.

Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson's Disease with Dementia and Dementia with Lewy Bodies.

Takemoto M, Sato K, Hatanaka N, Yamashita T, Ohta Y, Hishikawa N, Abe K.

J Alzheimers Dis. 2016;52(1):205-11. doi: 10.3233/JAD-150952.

PMID:
27060948
13.

Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.

Shimada H, Hirano S, Sinotoh H, Ota T, Tanaka N, Sato K, Yamada M, Fukushi K, Irie T, Zhang MR, Higuchi M, Kuwabara S, Suhara T.

Int J Geriatr Psychiatry. 2015 Nov;30(11):1105-13. doi: 10.1002/gps.4338. Epub 2015 Aug 17.

PMID:
26280153
14.

Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?

Fujishiro H, Iseki E, Murayama N, Yamamoto R, Higashi S, Kasanuki K, Suzuki M, Arai H, Sato K.

Psychogeriatrics. 2010 Sep;10(3):144-52. doi: 10.1111/j.1479-8301.2010.00325.x. Epub 2010 Aug 28.

PMID:
20860570
15.

Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits.

Granert O, Drzezga AE, Boecker H, Perneczky R, Kurz A, Götz J, van Eimeren T, Häussermann P.

J Nucl Med. 2015 Dec;56(12):1916-21. doi: 10.2967/jnumed.115.156067. Epub 2015 Sep 17.

PMID:
26383147
16.

Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.

Piggott MA, Ballard CG, Dickinson HO, McKeith IG, Perry RH, Perry EK.

Int J Neuropsychopharmacol. 2007 Apr;10(2):231-44. Epub 2006 Feb 1.

PMID:
16448581
17.

The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.

Colloby SJ, O'Brien JT, Fenwick JD, Firbank MJ, Burn DJ, McKeith IG, Williams ED.

Neuroimage. 2004 Nov;23(3):956-66.

PMID:
15528096
18.

Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.

Spehl TS, Hellwig S, Amtage F, Weiller C, Bormann T, Weber WA, Hüll M, Meyer PT, Frings L.

J Neuroimaging. 2015 Mar-Apr;25(2):281-8. doi: 10.1111/jon.12104. Epub 2014 Mar 5.

PMID:
24593796
19.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
20.

Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography.

Brooks DJ.

Mov Disord. 2009;24 Suppl 2:S742-7. doi: 10.1002/mds.22581. Review.

PMID:
19877240

Supplemental Content

Support Center